Kingsview Wealth Management LLC Makes New Investment in ARK Genomic Revolution ETF $ARKG

Kingsview Wealth Management LLC purchased a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the 4th quarter, Holdings Channel.com reports. The fund purchased 206,252 shares of the company’s stock, valued at approximately $5,975,000.

Several other large investors have also recently made changes to their positions in ARKG. Sunbelt Securities Inc. raised its stake in shares of ARK Genomic Revolution ETF by 734.3% during the third quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock worth $31,000 after acquiring an additional 984 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new position in shares of ARK Genomic Revolution ETF during the second quarter worth approximately $38,000. AlphaCore Capital LLC purchased a new position in shares of ARK Genomic Revolution ETF during the fourth quarter worth approximately $39,000. Advisory Services Network LLC purchased a new position in shares of ARK Genomic Revolution ETF during the third quarter worth approximately $58,000. Finally, Allworth Financial LP raised its stake in shares of ARK Genomic Revolution ETF by 39.9% during the fourth quarter. Allworth Financial LP now owns 2,061 shares of the company’s stock worth $60,000 after acquiring an additional 588 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

ARKG stock opened at $34.64 on Friday. ARK Genomic Revolution ETF has a one year low of $20.46 and a one year high of $35.12. The company’s 50 day moving average price is $28.99 and its two-hundred day moving average price is $29.46.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.